Fonte: Cellular Oncology. Unidades: ICB, FMRP
Assuntos: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, CITOESQUELETO, EXPRESSÃO GÊNICA, GENÔMICA, TRANSDUÇÃO DE SINAL CELULAR
ABNT
SILVA, Jean Carlos Lipreri da et al. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cellular Oncology, v. 44, n. 5, p. 1105-1117, 2021Tradução . . Disponível em: https://doi.org/10.1007/s13402-021-00621-0. Acesso em: 18 ago. 2024.APA
Silva, J. C. L. da, Silva, J. L. C., Lima, K., Vicari, H. P., Lazarini, M., Costa-Lotufo, L. V., et al. (2021). Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cellular Oncology, 44( 5), 1105-1117. doi:10.1007/s13402-021-00621-0NLM
Silva JCL da, Silva JLC, Lima K, Vicari HP, Lazarini M, Costa-Lotufo LV, Traina F, Machado Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia [Internet]. Cellular Oncology. 2021 ; 44( 5): 1105-1117.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1007/s13402-021-00621-0Vancouver
Silva JCL da, Silva JLC, Lima K, Vicari HP, Lazarini M, Costa-Lotufo LV, Traina F, Machado Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia [Internet]. Cellular Oncology. 2021 ; 44( 5): 1105-1117.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1007/s13402-021-00621-0